Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

NCT07308717 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT07308717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07308717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Phase 4
Overall status
Recruiting
Start date
December 16, 2025
Completion date
December 16, 2027
Enrollment
1,896 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer